| Discordance in informed consent response on the basis of demographic factors: brief report. | |
| | |
MedLine Citation:
|
PMID: 20597728 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
During an outcomes study of spasticity treatment at a developmental center for 62 residents with profound intellectual disabilities, either botulinum toxin A (BTX-A), intrathecal baclofen (ITB), or both were recommended with physical and occupational therapy. Conservators consented to BTX-A more than ITB (p = .021). Court-appointed conservators were more likely to provide consent for treatment than family members (p = .026). Nonparents consented more than parents (p = .009). Finally, Caucasian conservators were more likely to consent to treatment than African American conservators (p = .036), but ethnicity of the resident did not influence consent. Gender of resident or conservator did not influence rate of consent. This report highlights disparities in surrogate consent giving for individuals with intellectual disabilities and indicates a need for more research to ensure that this vulnerable population has access to appropriate treatments. |
| | |
Authors:
|
Karen R Nunez-Wallace; Chandler E Gill; Courtney H Harrison; Henry M Taylor; P David Charles |
Related Documents
:
|
11073038 - Norway: valid (as opposed to informed) consent. 20534218 - Ethical issues with informed consent from potential living kidney donors. 16449888 - Ethics and information technology: how nurses balance when integrity and trust are at s... 9873278 - Informed consent: do we achieve it? what are the elements that help create it? 21500988 - Barrels xxiii: barrels by the shore. 8027698 - "assault weapons" revisited--an analysis of the ama report. |
Publication Detail:
|
Type: Comparative Study; Journal Article |
Journal Detail:
|
Title: Intellectual and developmental disabilities Volume: 48 ISSN: 1934-9491 ISO Abbreviation: Intellect Dev Disabil Publication Date: 2010 Jun |
Date Detail:
|
Created Date: 2010-07-05 Completed Date: 2010-08-26 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101299965 Medline TA: Intellect Dev Disabil Country: United States |
Other Details:
|
Languages: eng Pagination: 175-9 Citation Subset: IM |
Affiliation:
|
Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
African Americans Baclofen / administration & dosage* Botulinum Toxin Type A / administration & dosage* Caregivers / legislation & jurisprudence* European Continental Ancestry Group Female Humans Informed Consent / legislation & jurisprudence* Injections, Intramuscular Injections, Spinal Legal Guardians / legislation & jurisprudence* Male Mental Retardation / ethnology, rehabilitation* Muscle Relaxants, Central / administration & dosage* Muscle Spasticity / ethnology, rehabilitation* Occupational Therapy* Parents* Physical Therapy Modalities* Residential Facilities Socioeconomic Factors |
| Chemical | |
Reg. No./Substance:
|
0/Botulinum Toxin Type A; 0/Muscle Relaxants, Central; 1134-47-0/Baclofen |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Erratum.
Next Document: Turning the educability narrative: Samuel A. Kirk at the intersection of learning disability and "me...